MARY FISHER
CIK 1272360 · Chief Operating Officer · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.0K
Companies
6
Total Filings
55
Lifetime Open-Market Net
-$3.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRMAW | Director | 196,946 | $0.01 | $2.0K | $0 | 9 | 2026-01-06 |
| Sientra, Inc. (SIEN) Delisted | Director | 19,581 | $0.17 | $3.4K | $0 | 6 | 2023-06-20 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | 3,319 | $15.90 | $52.8K | $0 | 1 | 2018-12-11 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 44,460 | — | — | $100.6K | 21 | 2018-10-02 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | -$2.65M | 9 | 2017-04-28 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief Operating Officer | 59,830 | $0.66 | $39.5K | -$1.01M | 9 | 2007-07-05 |
Recent Filings · Page 3 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-03 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +3,571 | $0 | EDGAR |
| 2017-10-03 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +3,521 | $0 | EDGAR |
| 2017-07-05 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +3,205 | $0 | EDGAR |
| 2017-06-23 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-28 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Other (J) | −10,122 | $0 | EDGAR |
| 2017-04-04 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +2,673 | $0 | EDGAR |
| 2017-01-04 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +3,267 | $5.0K | EDGAR |
| 2016-10-04 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +698 | $0 | EDGAR |
| 2016-07-05 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +959 | $0 | EDGAR |
| 2016-06-23 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | +6,199 | $175.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.